Tina Noergaard Munch1, Marie-Louise Hee Rasmussen2, Jan Wohlfahrt2, Marianne Juhler3, Mads Melbye2. 1. Department of Epidemiology Research, Statens Serum Institute, Copenhagen, Denmark Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark. 2. Department of Epidemiology Research, Statens Serum Institute, Copenhagen, Denmark. 3. Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark.
Abstract
OBJECTIVES: To investigate the associations between isolated congenital hydrocephalus (CHC) and maternal characteristics, maternal medical diseases, and medicine intake during pregnancy as well as birth characteristics of the child in a retrospective, register-based, nationwide cohort study. Furthermore, to identify the risk factors unique for isolated CHC as compared to syndromic CHC. METHODS: We established a cohort of all children born in Denmark between 1978 and 2008. Information on CHC and maternal medical diseases were obtained from the National Patient Discharge Register, maternal intake of medicine during pregnancy from the National Prescription Drug Register, and birth characteristics of the child from the Danish National Birth Register. Rate ratios (RR) of isolated and syndromic CHC with 95% CI were estimated using log-linear Poisson regression. RESULTS: In a cohort of 1928666 live-born children, we observed 1193 cases of isolated CHC (0.062/1000) born children. First-borns had an increased risk of isolated CHC compared to later-borns (1.32 95% CI 1.17 to 1.49) (0.72/1000 born children). First trimester exposure to maternal use of antidepressants was associated with a significantly increased risk of isolated CHC compared to unexposed children (RR 2.52, 95% CI 1.47 to 4.29) (1.5/1000 born children). Risk factors also found for syndromic CHC were: Male gender, multiples and maternal diabetes. CONCLUSIONS: The higher risk for isolated CHC in first-born children as well as behavioural aspects and comorbidities associated with maternal use of antidepressants, should be the targets for future research. Potential biological pathways by which antidepressants may cause hydrocephalus remain to be elucidated. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVES: To investigate the associations between isolated congenital hydrocephalus (CHC) and maternal characteristics, maternal medical diseases, and medicine intake during pregnancy as well as birth characteristics of the child in a retrospective, register-based, nationwide cohort study. Furthermore, to identify the risk factors unique for isolated CHC as compared to syndromic CHC. METHODS: We established a cohort of all children born in Denmark between 1978 and 2008. Information on CHC and maternal medical diseases were obtained from the National Patient Discharge Register, maternal intake of medicine during pregnancy from the National Prescription Drug Register, and birth characteristics of the child from the Danish National Birth Register. Rate ratios (RR) of isolated and syndromic CHC with 95% CI were estimated using log-linear Poisson regression. RESULTS: In a cohort of 1928666 live-born children, we observed 1193 cases of isolated CHC (0.062/1000) born children. First-borns had an increased risk of isolated CHC compared to later-borns (1.32 95% CI 1.17 to 1.49) (0.72/1000 born children). First trimester exposure to maternal use of antidepressants was associated with a significantly increased risk of isolated CHC compared to unexposed children (RR 2.52, 95% CI 1.47 to 4.29) (1.5/1000 born children). Risk factors also found for syndromic CHC were: Male gender, multiples and maternal diabetes. CONCLUSIONS: The higher risk for isolated CHC in first-born children as well as behavioural aspects and comorbidities associated with maternal use of antidepressants, should be the targets for future research. Potential biological pathways by which antidepressants may cause hydrocephalus remain to be elucidated. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Juan Antonio Gili; Jorge Santiago López-Camelo; Wendy N Nembhard; Marian Bakker; Hermien E K de Walle; Erin B Stallings; Vijaya Kancherla; Paolo Contiero; Saeed Dastgiri; Marcia L Feldkamp; Amy Nance; Miriam Gatt; Laura Martínez; María Aurora Canessa; Boris Groisman; Paula Hurtado-Villa; Karin Källén; Danielle Landau; Nathalie Lelong; Margery Morgan; Jazmín Arteaga-Vázquez; Anna Pierini; Anke Rissmann; Antonin Sipek; Elena Szabova; Wladimir Wertelecki; Ignacio Zarante; Mark A Canfield; Pierpaolo Mastroiacovo Journal: Birth Defects Res Date: 2022-05-28 Impact factor: 2.661
Authors: Albeliz Santiago-Colón; Carissa M Rocheleau; I-Chen Chen; Wayne Sanderson; Martha A Waters; Christina C Lawson; Peter H Langlois; Janet D Cragan; Jennita Reefhuis Journal: Birth Defects Res Date: 2020-01-14 Impact factor: 2.661